| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2003 | WO2003000677A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | WO2003000676A1 1,2,4-trioxolane antimalarials |
| 01/03/2003 | WO2003000672A1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000670A1 A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000666A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000660A1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000633A2 A process for the isolation of a major harmful oxidant from cigarette smoke |
| 01/03/2003 | WO2003000344A1 Use of phospholipids for the prevention 0f surgical adhesions |
| 01/03/2003 | WO2003000343A2 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000308A1 Drug delivery devices |
| 01/03/2003 | WO2003000301A1 Combination of a ppar-alpha ligand and glucocorticoid for the treatment or prevention of inflammation |
| 01/03/2003 | WO2003000295A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | WO2003000294A1 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| 01/03/2003 | WO2003000293A1 Pharmaceutical formulation |
| 01/03/2003 | WO2003000292A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | WO2003000289A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | WO2003000285A1 Tissue-specific transporter inhibitor |
| 01/03/2003 | WO2003000281A1 Neuroprotection and/or neurorestoration via the neural avtivin type iib receptor |
| 01/03/2003 | WO2003000276A1 Anti-aromatase composition consisting of a mixture from plants extracts |
| 01/03/2003 | WO2003000272A1 Medicaments containing tetrahydroisoquinoline derivatives |
| 01/03/2003 | WO2003000269A2 Novel use for pde 10a inhibitors |
| 01/03/2003 | WO2003000268A1 Use of na+ channel blockers and aspirin in manufacturing drugs for producing analgesia synergistically in mammals |
| 01/03/2003 | WO2003000267A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | WO2003000266A1 Novel quinolines and uses thereof |
| 01/03/2003 | WO2003000265A1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 01/03/2003 | WO2003000264A1 Antihistamines for the treatment of nasal congestion and nasal obstruction |
| 01/03/2003 | WO2003000263A1 Rapid onset formulation |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000261A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | WO2003000260A1 Thiazolyl amides and their use as antiviral drugs |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000258A1 Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000257A1 TGF-ß SUPERFAMILY PRODUCTION/SECRETION PROMOTER |
| 01/03/2003 | WO2003000256A1 Substituted oxazolidinones for combinational therapy |
| 01/03/2003 | WO2003000253A1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000252A1 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000249A1 Function regulator for retinoid relative receptor |
| 01/03/2003 | WO2003000248A1 Liquid composition |
| 01/03/2003 | WO2003000247A1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 01/03/2003 | WO2003000246A1 The use of rhein and derivatives thereof in pain treatment |
| 01/03/2003 | WO2003000245A1 Compounds for use in disorders associated with mast cell or basophil activity |
| 01/03/2003 | WO2003000244A1 Benzenesulfonyl(thio)ureas for the treatment of septic shock and sirs |
| 01/03/2003 | WO2003000243A1 Antimicrobial nanoemulsion compositions and methods |
| 01/03/2003 | WO2003000242A2 Method for the treatment of lymphedema using guaifenesin |
| 01/03/2003 | WO2003000241A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 01/03/2003 | WO2003000240A2 Stable powder inhalation dosage formulation |
| 01/03/2003 | WO2003000239A1 Stable pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000235A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 01/03/2003 | WO2003000228A2 Method for high through put screening using a small scale mill or microfluidics |
| 01/03/2003 | WO2003000226A2 Pharmaceutical compositions containing polymer and drug assemblies |
| 01/03/2003 | WO2003000225A2 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 01/03/2003 | WO2003000224A1 Compositions with controlled release of lactic acid at vaginal level |
| 01/03/2003 | WO2003000221A1 Use of quaternary polyammonium in the treatment of acne and cutaneous disorders linked to hyperseborrhoea |
| 01/03/2003 | WO2003000220A2 Use of 1,2-decandiol for combating germs causing body odour |
| 01/03/2003 | WO2003000208A1 Topical composition comprising a cytotoxic product |
| 01/03/2003 | WO2003000202A2 Particles for inhalation having rapid release properties |
| 01/03/2003 | WO2003000200A2 β-2'-OR 3'-HALONUCLEOSIDES |
| 01/03/2003 | WO2003000199A2 Ilt3 and ilt4-related compositions and methods |
| 01/03/2003 | WO2003000195A2 Method and material for treating immune diseases |
| 01/03/2003 | WO2003000191A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 01/03/2003 | WO2003000190A2 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000183A2 Method of treating atherosclerosis and other inflammatory diseases |
| 01/03/2003 | WO2003000182A2 Ppar-alpha ligands for the treatment or prevention of cachexia |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000178A2 Black soybean polysaccharides |
| 01/03/2003 | WO2003000177A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000175A2 Pediatric formulation of gatifloxacin |
| 01/03/2003 | WO2003000174A2 Compositions and methods for intracellular delivery |
| 01/03/2003 | WO2003000173A2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 01/03/2003 | WO2003000172A2 Methods, pharmaceutical compositions, oral compositions, filters and tobacco products for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject |
| 01/03/2003 | WO2003000158A1 Pharmaceutical composition |
| 01/03/2003 | WO2003000156A1 Zero-order prolonged release coaxial implants |
| 01/03/2003 | WO2003000118A2 Method for enhancing the effectiveness of cancer therapies |
| 01/03/2003 | WO2003000075A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | WO2003000056A1 Joint lubrication with p2y purinergic receptor agonists |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000023A2 Method of treating hyperproliferative diseases using active vitamin d analogues |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000010A2 Adenosyl-cobalamin fortified compositions |
| 01/03/2003 | WO2003000009A2 Stimulation of vascularization with vegf-b |
| 01/03/2003 | WO2002090068A1 Vehicle used to apply chemical compounds to wood |
| 01/03/2003 | WO2002088101A3 Inhibitors of bace |
| 01/03/2003 | WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002083656A3 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 01/03/2003 | WO2002083061A3 The use of beta 1,3 - glucan - containing compositions to potentiate immune responses ______________________________________________ |
| 01/03/2003 | WO2002081661A3 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/03/2003 | WO2002080915A3 Composition for the treatment of night sight problems (halos, coma and glare) comprising aceclidine |